1. Carabello BA: Clinical practice. Aortic stenosis.
NEJM 2002; 346:677.
[PubMed: 11870246]
2. Tornos P, Sambola A, Permanyer-Miralda G, et al: Long-term outcome of surgically treated aortic regurgitation: influence of guideline adherence toward early surgery.
J Am Coll Cardiol 2006; 47:1012.
[PubMed: 16516086]
3. Gott VL, Alejo DE, Cameron DE: Mechanical heart valves: 50 years of evolution. Ann Thorac Surg 2003; 76:S2230.
4. Hufnagel CA, Harvey WP: The surgical correction of aortic regurgitation preliminary report.
Bull Georgetown Univ Med Cent 1953; 6:60.
[PubMed: 12997885]
5. Shiono M, Sezai Y, Sezai A, et al: Long-term results of the cloth-covered Starr-Edwards ball valve.
Ann Thorac Surg 2005; 80:204.
[PubMed: 15975368]
6. Gao G, Wu Y, Grunkemeier GL, et al: Forty-year survival with the Starr-Edwards heart valve prosthesis.
J Heart Valve Dis 2004; 13:91.
[PubMed: 14765846]
7. Ezekowitz MD: Anticoagulation management of valve replacement patients. J Heart Valve Dis 2002; 11(Suppl 1):S56.
8. Oxenham H, Bloomfield P, Wheatley DJ, et al: Twenty-year comparison of a Bjork-Shiley mechanical heart valve with porcine bioprostheses. Heart 2003; 89:697.
9. Emery RW, Anderson RW, Lindsay WG, et al: Clinical and hemodynamic results with the St. Jude Medical aortic valve prosthesis.
Surg Forum 1979; 30:235.
[PubMed: 538605]
10. Emery RW, Nicoloff DM: The St. Jude Medical cardiac valve prosthesis: in vitro studies.
J Thorac Cardiovasc Surg 1979; 78:269.
[PubMed: 459535]
11. Nicoloff DM, Emery RW, Arom KV, et al: Clinical and hemodynamic results with the St. Jude Medical cardiac valve prosthesis. J Thorac Cardiovasc Surg 1982; 82:674.
12. Emery RW, Emery AM, Raikar GV, et al: Anticoagulation for mechanical heart valves: a role for patient based therapy.
J Thrombosis Thrombolysis 2008;25:18-25.
[PubMed: 18060537]
13. Sezai A, Shiono M, Orime Y, et al: Evaluation of valve sound and its effects on ATS prosthetic valves in patients' quality of life.
Ann Thorac Surg 2000; 69:507.
[PubMed: 10735689]
14. Emery RW, Krogh CC, Jones DJ, et al: Five-year follow up of the ATS mechanical heart valve.
J Heart Valve Dis 2004; 13:231.
[PubMed: 15086262]
15. Bach DS, Sakwa MP, Goldbach M, et al: Hemodynamics and early clinical performance of the St. Jude Medical Regent mechanical aortic valve.
Ann Thorac Surg 2002; 74:2003.
[PubMed: 12643387]
16. Gelsomino S, Morocutti G, Da Col P, et al: Preliminary experience with the St. Jude Medical Regent mechanical heart valve in the aortic position: early in vivo hemodynamic results.
Ann Thorac Surg 2002; 73:1830.
[PubMed: 12078777]
17. Emery RW, Emery AM: Letter to the editor.
J Thorac Cardiovasc Surg 2006; 131:760.
[PubMed: 16515947]
18. Hammermeister KE, Sethi GK, Henderson WG, et al: A comparison of outcomes in men 11 years after heart valve replacement with a mechanical valve or bioprosthesis.
NEJM 1993; 328:1289.
[PubMed: 8469251]
19. Autschbach R, Walther T, Falk V: Prospectively randomized comparison of different mechanical aortic valves. Circulation 2000; 102:III-1.
20. Walther T, Falk V, Tigges R, et al: Comparison of On-X and SJM HP bileaflet aortic valves.
J Heart Valve Dis 2000; 9:403.
[PubMed: 10888098]
21. Masters RG, Helou J, Pipe AL, Keon WJ: Comparative clinical outcomes with St. Jude Medical, Medtronic Hall and Carbomedics mechanical heart valves.
J Heart Valve Dis 2001; 10:403.
[PubMed: 11380109]
22. Chambers J, Roxburgh J, Blauth C, et al: A randomized comparison of the MCRI On-X and Carbomedics Top Hat bileaflet mechanical replacement aortic valves: early postoperative hemodynamic function and clinical events.
J Thorac Cardiovasc Surg 2005; 130:759.
[PubMed: 16153925]
23. Khan SS, Trento A, DeRobertis M, et al: Twenty-year comparison of tissue and mechanical valve replacement.
J Thorac Cardiovasc Surg 2001; 122:257.
[PubMed: 11479498]
24. Brown ML, Schare HV, Lahr BD, et al: Aortic valve replacement in patients aged 50 to 70 years: Improved outcome with mechanical versus biologic prosthesis.
J Thorac Cardiovasc Surg 2008;135:878.
[PubMed: 18374773]
25. deVincentiis C, Kunkl AB, Trimarchi S, et al. Aortic valve replacement in octogenarians: is biologic valve the unique solution? Ann Thorac Surg 2008; 85:1296-1301
26. Butchart EG, Payne N, Li H, et al: Better anticoagulation control improves survival after valve replacement.
J Thorac Cardiovasc Surg 2002; 123:715.
[PubMed: 11986600]
27. Butchart EG, Ionescu A, Payne N, et al: A new scoring system to determine thromboembolic risk after heart valve replacement. Circulation 2003; 108(Suppl II):II-68.
28. Akins CW, Buckley MJ, Daggett WM, et al: Risk of reoperative valve replacement for failed mitral and aortic bioprostheses.
Ann Thorac Surg 1998; 65:1545.
[PubMed: 9647056]
29. Emery RW, Arom KV, Krogh CC, et al: Reoperative valve replacement with the St. Jude Medical valve prosthesis: long-term follow up. J Am Coll Cardiol 2004; 435:438A.
30. Potter DD, Sundt TM 3rd, Zehr KJ, et al: Operative risk of reoperative aortic valve replacement.
J Thorac Cardiovasc Surg 2005; 129:94.
[PubMed: 15632830]
32. Emery RW, Krogh CC, Arom DV, et al: The St. Jude Medical cardiac valve prosthesis: a 25-year experience with single valve replacement.
Ann Thorac Surg 2005; 79:776.
[PubMed: 15734375]
33. Emery RW, Arom KV, Nicoloff DM: Utilization of the St. Jude Medical prosthesis in the aortic position.
Semin Thorac Cardiovasc Surg 1996; 8:231.
[PubMed: 8843513]
34. Emery RW, Arom KV, Kshettry VR, et al: Decision making in the choice of heart valve for replacement in patients aged 60–70 years: twenty-year follow up of the St. Jude Medical aortic valve prostheses. J Heart Valve Dis 2002; 11(Suppl 1):S37.
35. Bakir MD, Casselman FP, Wellens F, et al: Minimally invasive versus standard approach aortic valve replacement: a study in 506 patients.
Ann Thorac Surg 2006;81:1599-1604
[PubMed: 16631641]
36. Lund O, Nielsen SL, Arildsen H, et al: Standard aortic St. Jude valve at 18 years: performance, profile and determinants of outcome.
Ann Thorac Surg 2000; 69:1459.
[PubMed: 10881823]
37. Aagaard J, Tingleff J, Hansen CN, et al: Twelve years' clinical experience with the Carbomedics prosthetic heart valve.
J Heart Valve Dis 2001; 10:177.
[PubMed: 11297204]
38. Butchart EG, Li H, Payne N, et al: Twenty years' experience with the Medtronic Hall valve.
J Thorac Cardiovasc Surg 2001; 121:1090.
[PubMed: 11385376]
39. Ikonomidis JS, Kratz JM, Crumbley AJ, et al: Twenty-year experience with the St. Jude Medical mechanical valve prosthesis. J Thorac Cardiovasc Surg 2003; 126:20022.
40. Koertke H, Korfer R: International normalized ratio self-management after mechanical heart valve replacement: is an early start advantageous? Ann Thorac Surg 2001; 72:44.
41. Montalescot G, Polle V, Collet JP, et al: Low molecular weight
heparin after mechanical heart valve replacement.
Circulation 2000; 101:1083.
[PubMed: 10715251]
42. Horstkotte D, Schulte H, Bircks W, Strauer B: Unexpected findings concerning thromboembolic complications and anticoagulation after complete 10-year follow-up of patients with St. Jude Medical prostheses.
J Heart Valve Dis 1993; 2:291.
[PubMed: 8269122]
43. Butchart EG, Lewis PA, Bethel JA, Breckenridge IM: Adjusting anticoagulation to prosthesis thrombogenicity and patient risk factors. Circulation 1991; 84(Suppl III):III-61.
44. Koertke H, Minami K, Boethig D, et al: INR self-management permits lower anticoagulation levels after mechanical heart valve replacement. Circulation 2003; 108(Suppl II):II-75.
45. Bonow RO, Carabello BA, Chatterjee BA, et al: ACC/AHA 2006 guidelines for the management of patients with valvular heart disease. J Am Coll Cardiol 2008;52;e1-142
46. American College of Chest Physicians: Sixth (2000) ACCP guidelines for antithrombotic therapy for prevention and treatment of thrombosis. Chest 2001; 119(1 Suppl):1S.
47. Horstkotte D, Piper C, Wiener X, et al: Improvement of prognosis by home control in patients with lifelong anticoagulant therapy. Ann Hematol 1996; 72(suppl D):AE3.
48. Koo S, Kucher N, Nguyen PL, et al: The effect of excessive anticoagulation on mortality and morbidity in hospitalized patients with anticoagulant-related major hemorrhage.
Arch Intern Med 2004; 164:1557.
[PubMed: 15277289]
49. Emery RW, Arom KV, Krogh CC, Joyce LD: Long-term results with the St. Jude Medical aortic valve: a 25-year experience. J Am Coll Cardiol 2004; 435:429A.
50. Horstkotte D, Schulte HD, Bircks W, Strauer BE: Lower intensity anticoagulation therapy results in lower complication rates with the St. Jude Medical prosthesis.
J Thorac Cardiovasc Surg 1994; 107:1136.
[PubMed: 8159036]
51. Turpie A, Gent M, Laupacis A, et al: A comparison of
aspirin with placebo in patients treated with
warfarin after heart valve replacement.
NEJM 1993; 329:524.
[PubMed: 8336751]
52. Massel D, Little SH: Risk and benefits of adding antiplatelet therapy to
warfarin among patients with prosthetic heart valves: a meta-analysis.
J Am Coll Cardiol 2001; 37:569.
[PubMed: 11216981]
53. Accola KD, Scott ML, Spector SD, et al: Is the St. Jude Medical mechanical valve an appropriate choice for elderly patients? A long-term retrospective study measuring quality of life.
J Heart Valve Dis 2006; 15:57.
[PubMed: 16480013]
54. Arom KV, Emery RW, Nicoloff DM, Petersen RJ: Anticoagulant related complications in elderly patients with St. Jude mechanical valve prostheses.
J Heart Valve Dis 1996; 5:505.
[PubMed: 8894990]
55. Masters RG, Semelhago LC, Pipe AL, Keon WJ: Are older patients with mechanical heart valves at increased risk?
Ann Thorac Surg 1999; 68:2169.
[PubMed: 10616996]
56. Davis EA, Greene PS, Cameron DE, et al: Bioprosthetic versus mechanical prostheses for aortic valve replacement in the elderly. Circulation 1996; 94(9 Suppl):II121.
57. Zimpfer D, Czerny M, Schuch P, et al: Long-term neurocognitive function after mechanical aortic valve replacement.
Ann Thorac Surg 2006; 81:29.
[PubMed: 16368330]
58. Lip GY, Hart RG, Conway DS: Antithrombotic therapy for atrial fibrillation.
BMJ 2002; 325:1022.
[PubMed: 12411366]
59. Garcia-Rinaldi R, Carro-Pagan C, Schaer HV, et al: Initial experience with dual antiplatelet thrombo prophylaxis with
clopidogrel and
aspirin in patients with mechanical aortic prosthesis.
J Heart Valve Dis 2009;18:617
[PubMed: 20099710]
60. Horstkotte D: Letter to the editor. Ann Thorac Surg 1996; 62:1566.
61. Akins CW: Results with mechanical cardiac valvular prostheses.
Ann Thorac Surg 1995; 60:1836.
[PubMed: 8787503]
62. David TE, Gott VL, Harker LA, et al: Mechanical valves.
Ann Thorac Surg 1996; 62:1567.
[PubMed: 8893619]
63. Maganti M, Rao V, Armstrong S, et al: Redo valvular surgery in elderly patients.
Ann Thorac Surg 2009;87:521-525
[PubMed: 19161771]
64. Grunkemeier GL, Li HH, Naftel DC, et al: Long-term performance of heart valve prostheses.
Curr Probl Cardiol 2000; 25:73.
[PubMed: 10709140]
65. Sawant D, Singh AK, Feng WC, et al: St. Jude Medical cardiac valves in small aortic roots: follow-up to sixteen.
J Thorac Cardiovasc Surg 1997; 113:499.
[PubMed: 9081094]
66. Piper C, Hering D, Langer C, Horstkotte D: Etiology of stroke after mechanical heart valve replacement: results from a ten-year prospective study.
J Heart Valve Dis 2008; 17:413-417.
[PubMed: 18751471]
67. Czer LS, Matloff JM, Chaux A, et al: The St. Jude valve: analysis of thromboembolism, warfarin-related hemorrhage, and survival.
Am Heart J 1987; 114:389.
[PubMed: 3604897]
68. Durrleman N, Pellerin M, Bouchard D, et al: Prosthetic valve thrombosis: twenty-year experience at the Montreal Heart Institute.
J Thorac Cardiovasc Surg 2004; 127:1388.
[PubMed: 15115997]
69. Van Nooten GJ, Van Belleghem Y, Caes F, et al: Lower-intensity anticoagulation for mechanical heart valves: a new concept with the ATS bileaflet aortic valve. J Heart Valve Dis 2003; 12:495.
70. Schaff HV, Carrel TP, Jamieson WRE, et al: Paravalvular leak and other events in silzone-coated mechanical heart valves: a report from AVERT.
Ann Thorac Surg 2002; 73:785.
[PubMed: 11899956]
71. De Cicco G, Lorusso R, Colli A, et al: Aortic valve periprosthetic leakage, anatomic observations and surgical results. Ann Thorac Surg 2005; 79:1480.
72. Baudet EM, Oca CC, Roques XF, et al: A 5½ year experience with the St. Jude Medical cardiac valve prosthesis. Early and late results of 737 valve replacements in 671 patients.
J Thorac Cardiovasc Surg 1985; 90:137.
[PubMed: 3874324]
73. Rahimtoola SH: The problem of valve prosthesis patient mismatch.
Circulation 1978; 58:20.
[PubMed: 348341]
74. Pibarot P, Dumesnil JG: Hemodynamic and clinical impact of prosthesis-patient mismatch in the aortic valve position and its prevention.
J Am Coll Cardiol 2000; 36:1131.
[PubMed: 11028462]
75. Hanayama N, Christakis GT, Mallidi HR, et al: Patient prosthesis mismatch is rare after aortic valve replacement: valve size may be irrelevant.
Ann Thorac Surg 2002; 73:1822.
[PubMed: 12078776]
76. Blackstone EH, Cosgrove DM, Jamieson WRE, et al: Prosthesis size and long-term survival after aortic valve replacement.
J Thorac Cardiovasc Surg 2003; 126:783.
[PubMed: 14502155]
77. Blais C, Dumesnil JG, Baillot R, et al: Impact of valve prosthesis patient mismatch on short-term mortality after aortic valve replacement.
Circulation 2003; 108:983.
[PubMed: 12912812]
78. Moon MR, Pasque MK, Munfakh NA, et al: Prosthesis-patient mismatch after aortic valve replacement: impact of age and body size on late survival.
Ann Thorac Surg 2006; 81:481.
[PubMed: 16427836]
79. Emery RW, Krogh CC, Arom KV, et al: Patient-prosthesis mismatch: Impact on patient survival and valve related events: a 25-year experience with the St. Jude Medical valve prosthesis. Presented at the Society of Thoracic Surgeons at the 41st Annual Meeting, San Antonio, TX. January 2005.
80. Pibarot P, Dumesnil JG: Patient-prosthesis mismatch and the predictive use of indexed effective orifice area: is it relevant? Cardiac Surg Today 2003; 1:43.
81. Riberiro PA, Al Zaibag M, Idris M, et al: Antiplatelet drugs and the incidence of thromboembolic complications of the St. Jude Medical aortic prosthesis in patients with rheumatic heart disease. J Thoracic Cardiovasc Surg 1986; 91:92.
82. Ananthasubramaniam K, Beattie JN, Rosman HS, et al: How safely and for how long can
warfarin therapy be withheld in prosthetic heart valve patients hospitalized with a major hemorrhage?
Chest 2001; 119:478.
[PubMed: 11171726]
83. Hartz RS, LoCicero J 3rd, Kucich V, et al: Comparative study of
warfarin versus antiplatelet therapy in patients with a St. Jude Medical valve in the aortic position.
J Thorac Cardiovasc Surg 1986; 92:684.
[PubMed: 3762199]
84. Garcia-Rinaldi R: Letter to the editor.
Ann Thorac Surg 2006; 81:787.
[PubMed: 16427911]
85. Emery RW, Emery AM: Letter to the editor: reply to Garcia-Rinaldi. Ann Thorac Surg 2006; 81:788.
86. Cannegieter SC, Rosendaal FR, Briet E: Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses.
Circulation 1994; 89:635.
[PubMed: 8313552]
87. Cabalka AK, Emery RW, Petersen RJ: Long-term follow-up of the St. Jude Medical prosthesis in pediatric patients. Ann Thorac Surg 1995; 60:S618.
88. Emery RW, Erickson CA, Arom KV, et al: Replacement of the aortic valve in patients under 50 years old with the St. Jude Medical prosthesis.
Ann Thorac Surg 2003; 75:1815.
[PubMed: 12822621]